<- Go Home
Varian Medical Systems, Inc.
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through the Oncology Systems and Proton Solutions segments. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed-field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, artificial intelligence-based adaptive radiotherapy, and brachytherapy, as well as quality assurance equipment. Its products include linear accelerators, brachytherapy afterloaders, treatment accessories, and quality assurance software; information management; treatment planning; image processing; clinical knowledge exchange; patient care management; decision-making support; and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians’ offices, medical oncology practices, radiotherapy centers, and cancer care clinics. The company has a strategic agreement with McKesson Corp. to supply treatment delivery systems and planning, services, and radiotherapy information system solutions to its U.S. Oncology Network and Vantage Oncology affiliated sites of care; a strategic partnership with Siemens AG to represent Siemens diagnostic imaging products to radiation oncology clinics in the United States and other select markets; and a collaboration with Google Cloud. Varian Medical Systems, Inc. was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. Varian Medical Systems, Inc. was founded in 1948 and is based in Palo Alto, California, with an additional branch in Atlanta, Georgia. As of April 15, 2021, Varian Medical Systems, Inc. operates as a subsidiary of Siemens Healthineers AG.
Market Cap
$16.3B
Volume
997.5K
Cash and Equivalents
$773.3M
EBITDA
$524.5M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$1.4B
Profit Margin
43.92%
52 Week High
$177.38
52 Week Low
$103.67
Dividend
N/A
Price / Book Value
7.26
Price / Earnings
58.40
Price / Tangible Book Value
12.08
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
$425.0M
Return on Equity
13.51%
Return on Assets
5.92
Cash and Short Term Investments
$773.3M
Debt
$350.5M
Equity
$2.2B
Revenue
$3.1B
Unlevered FCF
$417.4M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium